🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSemaglutide (Ozempic / Wegovy)Semaglutide mechanism of action: hypothalamic GLP-1R binding and satiety — what worked for you? Page 6

Semaglutide mechanism of action: hypothalamic GLP-1R binding and satiety — what worked for you?

VendorMark Fri, Jan 31, 2025 at 9:53 PM 54 replies 2,401 viewsPage 6 of 11
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Mar 13, 2025 at 12:14 PM#26

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

29 2SleepFixSam, PurityPaulOR, MaxMetOK and 26 others
Reply Quote Save Share Report
PeptideSynthNJ
Member
234
1,234
Aug 2024
Princeton, NJ
Mar 18, 2025 at 11:42 AM#27

One thing that is still open after TrialNerd_Beth’s answer:

What did you change at the same time, and can you separate the two now?

Last edited: Mar 18, 2025 at 3:42 PM
30 3NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 27 others
Reply Quote Save Share Report
FranDenver
Member
267
1,123
Oct 2024
Denver, CO
Mar 23, 2025 at 11:07 AM#28
wendy_avl said:
One habit that pays for itself: post the method alongside the number.

I read this differently from wendy_avl, on substance rather than tone. The objection nobody has made: this only works if the measurement is doing what we assume it is doing, and that assumption has not been tested here.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

31 4BariatricNurseD, MASHdoc_SA, GenomicsKate and 28 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Mar 28, 2025 at 10:29 AM#29
wendy_avl said:
One habit that pays for itself: post the method alongside the number.

No disagreement, though it depends on where somebody is starting from, and this thread has been assuming a starting point nobody stated.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

Correct me if the detail matters more than I have assumed.

Last edited: Mar 28, 2025 at 2:29 PM
32 5tammy_FL, Dr.LipidDallas, alex_tucson and 29 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Apr 2, 2025 at 9:48 AM#30

Closing the loop on my own question.

Following this thread I went back and re-read the extension data properly. The point about trough rather than peak explains the pattern I was seeing on day six, which I had been blaming on the vial.

4 2claudia_zurich, nancy_portland, rick_sfbay and 1 other
Reply Quote Save Share Report
14567811

Similar Threads

STEP 1-5 trials comprehensive summary — efficacy endpoints compiled12 replies
Oral semaglutide 50mg Phase 3 — OASIS program results16 replies
Semaglutide pharmacokinetics — half-life, Tmax, steady state modeling10 replies
Compounded semaglutide stability data — temperature and light sensitivity16 replies
0.25mg → 2.4mg titration: optimal schedule based on clinical data6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register